The orthobiologics market in Asia is estimated to grow to around $703.9 million by 2018


Posted October 1, 2014 by tonypandrew

The orthobiologics market in Asia is estimated to grow to around $703.9 million by 2018, at a developing CAGR of 5.2% from 2013 to 2018.

 
The Asian orthobiologics report defines and segments the concerned market in Asia with analysis and forecast of revenue. The orthobiologics market in Asia is estimated to grow to around $703.9 million by 2018, at a developing CAGR of 5.2% from 2013 to 2018.
Browse through the TOC of the Asian orthobiologics market, to get an idea of the in-depth analysis provided. This also provides a glimpse of the segmentation of orthobiologics market in the same region, and is supported by various tables and figures.

http://www.micromarketmonitor.com/market/asia-orthobiologics-7943449547.html

The major factors driving the growth of the Asian orthopedic devices market is the increase in the region’s middle class population, having higher disposable income and spending capabilities for orthopedic conditions. Besides, the change in the mindset of people with growing medical awareness has resulted into people wishing to have better and active lifestyle, by making use of less invasive procedures that have several benefits such as less pain, less scarring, shorter hospital stay and higher accuracy.
The main consumers of the orthobiologics market who undergo several surgeries such as total hip or knee replacement and spinal fusion is the ageing population. Besides, the old population, the cases of road accidents and rise in the number of sports injuries has also accelerated the growth in this market. In Asia, the devices are advanced and are less expensive. The major markets in this region include China, Japan, and India. Japan is the largest market for orthopedic products and orthobiologics market, and in 2014, it accounts for 40% of the Asian market.
This market is segmented and forecast on the basis of various types of products, namely, bone allograft, bone graft substitutes, bone growth factors & spinal stimulation, stem cell therapy, and viscosupplementation. The market is further segmented and forecast on the basis of major countries, such as the Japan, China, and India. The market is also segmented and analyzed further on the basis of the end users.
This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By micromarketmonitor
Country United States
Categories Health
Tags asian orthobiologics market
Last Updated October 1, 2014